Glen is currently the head of External Operations at Vir Biotechnology and previously held positions at Amgen, Immunex, and Genentech. He has over 30 years of industry experience in commercial and clinical manufacturing, facility design and licensure, process development, MSAT, business development, and strategic partnerships. Glen has delivered products across multiple modalities (fusion protein, mAb, bi-specific, small molecule, viral vector, siRNA) and all stages of manufacture and testing.